Silexion Therapeutics Corp

SLXN · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.0B · 13 employees
81
SEC Filings
$4.9095
Close 2026-05-29
13
Employees

Business Summary

PART I . Unless the context otherwise requires, in this Business section, the terms we, us and our generally refer to: (i) for the period following the Closing of the Business Combination on August 15, 2024, Silexion Therapeutics Corp (formerly known as Biomotion Sciences), a Cayman Islands exempted company (Silexion) and its consolidated subsidiaries, including Silexion Therapeutics Ltd., an Israeli company (Silexion Israel), through which our business is primarily conducted, and, (ii) with res...

Latest Stock Quote

SLXN 2026-05-29 $4.9095 O:$4.29 H:$5.45 L:$4.064 Vol:0.3M VWAP:$4.8109
origin leaf: 622dc55d5bf6a8ace99373eec92013210fc078410fc27708dc09c68dbac0f63f

Next Earnings

Q2 FY2026 — expected 2026-09-15

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-172025-12-310001178913-26-000953EDGAR98K words
2025-03-182024-12-310001178913-25-000887EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001178913-25-003753EDGAR32K words
2025-08-122025-06-300001178913-25-002804EDGAR—
2025-05-132025-03-310001178913-25-001761EDGAR—
2024-11-142024-09-300001178913-24-003686EDGAR—
2024-08-292024-06-300001213900-24-073934EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-250001178913-26-001722EDGAR1K words
2026-03-240001178913-26-001615EDGAR—
2026-03-230001178913-26-001597EDGAR—
2026-02-030001178913-26-000289EDGAR—
2026-01-060001178913-26-000067EDGAR—
2025-12-160001178913-25-004067EDGAR—
2025-12-020001178913-25-003981EDGAR—
2025-11-250001178913-25-003949EDGAR—
2025-11-120001178913-25-003756EDGAR—
2025-09-300001178913-25-003444EDGAR—

81 total filings indexed. 64 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0002022416
TickerSLXN
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedE9
Websitehttps://silexion.com
Listed2024-08-16

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 1ab30e5e93b067037057b94e5641ecbfedde1479105fe9b7c2e469398ca42273
parent: d57f8926b6547387d5fd7372056ef36cbc647ec423dfc7c9c74d04f87e60f562
content hash: 906e2d7c6ff706c02235b71a958b12a6d9b55a7523ac24c25b4add838ac37acb
signed: 2026-06-02T19:02:39.242Z
sources: 8 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf